Group One Trading
ARLZ

Group One Trading’s Aralez Pharmaceuticals Inc. ARLZ Stock Holding History

Group One Trading’s Portfolio ARLZ Stock Details ARLZ Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2018
Q3 		– Sell
-45,671
Closed -$16K – 6020
2018
Q2 		$16K Buy
45,671
+700
+2% +$574 ﹤0.01% 4477
2018
Q1 		$67K Buy
44,971
+32,639
+265% +$57K ﹤0.01% 3506
2017
Q4 		$18K Buy
12,332
+11,000
+826% +$18.1K ﹤0.01% 4200
2017
Q3 		$3K Sell
1,332
-78,199
-98% -$105K ﹤0.01% 4623
2017
Q2 		$107K Buy
79,531
+35,590
+81% +$51.4K ﹤0.01% 3068
2017
Q1 		$94K Sell
43,941
-64,816
-60% -$244K ﹤0.01% 3028
2016
Q4 		$480K Buy
108,757
+68,520
+170% +$325K ﹤0.01% 1809
2016
Q3 		$195K Buy
+40,237
New +$183K ﹤0.01% 2490
2016
Q2 		– Sell
-32,963
Closed -$124K – 5368
2016
Q1 		$117K Buy
+32,963
New +$170K ﹤0.01% 2723

Other funds holding ARLZ

GT
Glenmede Trust Philadelphia, Pennsylvania $20.4B AUM

Group One Trading's ARLZ Position: Q3 2018 in Review

Group One Trading sold out of Aralez Pharmaceuticals Inc. (ARLZ) in Q3 2018, closing a stake of 45,671 shares — an estimated $16K sold.

Group One Trading first reported a position in ARLZ in Q1 2016 and held it in 9 quarters. The position peaked at $480K in Q4 2016. 4 funds tracked by Wall St. Rank hold ARLZ as of Q3 2018.

  • Group One Trading reported no remaining Aralez Pharmaceuticals Inc. position as of Q3 2018 after selling out during the quarter.
  • Group One Trading sold 45,671 Aralez Pharmaceuticals Inc. shares in Q3 2018, an estimated $16K.
  • Group One Trading first reported a position in Aralez Pharmaceuticals Inc. in Q1 2016 and held it in 9 quarters.
  • Group One Trading's Aralez Pharmaceuticals Inc. position peaked at $480K in Q4 2016.
  • 4 funds tracked by Wall St. Rank held Aralez Pharmaceuticals Inc. as of Q3 2018.

Based on Group One Trading's 13F filing for Q3 2018, filed 8 Nov 2018.